Cargando…

Functional analyses of glycosylated gag molecules derived from different gammaretroviruses

Detalles Bibliográficos
Autores principales:	Cuccurullo, Emilia Cristiana, Pistello, Mauro, Takeuchi, Yasuhiro, Miyazawa, Takayuki, Massimo, Pizzato
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847932/ http://dx.doi.org/10.1186/1742-4690-10-S1-P22

Ejemplares similares

Immunisation with the membrane proximal external region of gp41 of HIV-1 grafted into the transmembrane envelope protein of a gammaretrovirus
por: Strasz, N, et al.
Publicado: (2012)

Mouse "xenotropic" gammaretroviruses, XMRV and their XPR1 receptor
por: Baliji, Surendranath, et al.
Publicado: (2011)

The potential of small molecules to modulate glycosylation by media design
por: Brühlmann, David, et al.
Publicado: (2015)

P19-31. Neutralizing antibodies specific for the transmembrane envelope proteins of gammaretroviruses and of HIV-1 (2F5, 4E10): comparison of their action
por: Eschricht, M, et al.
Publicado: (2009)

Characterisation of a spumavirus Gag protein
por: Goldstone, David C, et al.
Publicado: (2013)

Role of receptor polymorphism and glycosylation in syncytium induction and host range variation of ecotropic mouse gammaretroviruses
por: Yan, Yuhe, et al.
Publicado: (2008)

Dynamics and frequency of Gag transmitted polymorphisms in Zambia
por: Schaefer, M, et al.
Publicado: (2012)

Understanding the nature of the Nef requirement for HIV-1 infectivity
por: Rosa, Annachiara, et al.
Publicado: (2013)

Post-transcriptional control of HIV-1 Gag expression
por: Phalora, Prabhjeet, et al.
Publicado: (2013)

Characterization and quantitation of fluorescent Gag virus-like particles
por: Gutiérrez-Granados, Sonia, et al.
Publicado: (2013)

Early presentation of HIV-1 KF11Gag and KK10Gag protective epitopes facilitate rapid CD8+ T cell activation and killing of virus infected cells
por: Kløverpris, HN, et al.
Publicado: (2012)

Identifying features of the lentiviral genome crucial for the establishment of latency
por: Ziglio, Serena, et al.
Publicado: (2013)

The mouse "xenotropic" gammaretroviruses and their XPR1 receptor
por: Kozak, Christine A
Publicado: (2010)

Origins of the Endogenous and Infectious Laboratory Mouse Gammaretroviruses
por: Kozak, Christine A.
Publicado: (2014)

Preferential targeting of co-evolving Gag residues in long-term non progressors
por: Sunshine, J, et al.
Publicado: (2012)

Endogenous retrovirus type W GAG and ENV antigenaemia in serum of schizophrenic patients
por: Bernard, Corinne, et al.
Publicado: (2009)

Expression of Gag and Pol from reconstructed HERV-Fc1, associated with multiple sclerosis
por: Nissen, Kari K, et al.
Publicado: (2011)

P04-32. Differential regulation of secondary antibody responses to Gag and Env proteins
por: Nabi, G, et al.
Publicado: (2009)

P17-14. Fitness-informed HIV-1 Gag-p24 vaccine design
por: Rolland, MM, et al.
Publicado: (2009)

Dissecting the contribution of Gag domain in resistance development in HIV-1 patients failing ARV therapy
por: Carli, Ilaria, et al.
Publicado: (2013)

P20-12. Heterogeneity of Gag mutational pathways in primary HIV-1 subtype C infection
por: Novitsky, V, et al.
Publicado: (2009)

Profiling of glycosylation gene expression in CHO fed-batch cultures in response to glycosylation-enhancing medium components
por: Boniface, Ryan, et al.
Publicado: (2013)

Gag-Vpu cross talk modulating HIV-1 envelope incorporation and infectivity in cell-type dependent manner
por: Gautam, Archana, et al.
Publicado: (2012)

Long-Term Infection and Vertical Transmission of a Gammaretrovirus in a Foreign Host Species
por: Sakuma, Toshie, et al.
Publicado: (2012)

Induction of HIV-1 Gag-specific memory T cells in Chacma baboons by MVA prime and VLP boost vaccine regimen
por: Singh, V, et al.
Publicado: (2012)

Limited evidence for alterations in Gag-mediated HIV replication capacity over the course of the North American epidemic (1979-present)
por: Cotton, L, et al.
Publicado: (2012)

Immune response after vaccination of HIV infected individuals receiving HAART with overlapping gag peptides pulsed on autologous cells
por: Kløverpris, H, et al.
Publicado: (2012)

P20-18. Diversity of Gag and Nef immunodominant regions in Brazilian HIV-1 B and F1 subtypes
por: Côrtes, FH, et al.
Publicado: (2009)

P16-49. Broad types of cytokines secreted by Gag-specific T cells from HIV infected patients on HAART
por: Montes, M, et al.
Publicado: (2009)

Placement of p6pol between tandem repeat HIV-1 protease domains reduces Gag cleavage efficiency
por: Chou, Tin-An, et al.
Publicado: (2013)

Xenotropic Murine Leukemia Virus–related Gammaretrovirus in Respiratory Tract
por: Fischer, Nicole, et al.
Publicado: (2010)

Glycosylation of human receptor guanylyl cyclase C
por: Arshad, Najla, et al.
Publicado: (2009)

Misfolding and interactions of Aß proteins: Insight from single molecule experiments and computational analyses
por: Zhengjian, Lv, et al.
Publicado: (2013)

Novel codon-optimized GM-CSF gene as an adjuvant to enhance the immunity of a DNA vaccine against HIV-1 gag
por: Qiu, Jian-Tai, et al.
Publicado: (2006)

Immunodominant Anti-Gag SLYNTVATL Responses in HIV-patients With More Than Five Years of HAART-induced Undetectable Plasma Viremia
por: Remenar, Anica, et al.
Publicado: (2005)

A pantothenate suxotroph of BCG rxpressing Gag confers enhanced HIV-specific immunogenicity compared to wildtype and perfingolysin expressing strains
por: Chetty, S, et al.
Publicado: (2012)

Gag-specific cellular immunity determines in vitro viral inhibition and in vivo virologic control following SIV challenges of vaccinated monkeys
por: Stephenson, KE, et al.
Publicado: (2012)

P16-16. Gag and Nef specific T-cell responses in HIV-1 infected long-term non-progressors in Uganda
por: Kyosiimire-Lugemwa, J, et al.
Publicado: (2009)

P17-24. Interfering overlapping epitopes contribute to the subdominance of an HLA-A2-restricted HIV Gag-specific epitope
por: Kan-Mitchell, J, et al.
Publicado: (2009)

P10-10. HIV-1 Gag virus like particles pseudotyped with CD40 ligand to stimulate innate immune responses
por: Köstler, J, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_er4p45agr5m1rdp7cd27cnf717